Regulatory update – GSK announces EU submission for Cervarix® two dose schedule

GlaxoSmithKline (GSK) plc today announced the submission of a regulatory application in the European Union for a two dosing schedule in 9-14 year old girls for its cervical cancer vaccine.

Source: GSK news - August 7, 2013 Category: Pharmaceuticals Source Type: news